[1]
J. Hill and Y. Li, “Myasthenia Gravis Exacerbation Following BRAF and MEK Inhibitor Therapy”, rrnmf, vol. 4, no. 2, pp. 16–17, Jun. 2023, doi: 10.17161/rrnmf.v4i2.18636.